Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07211412 · ClinicalTrials.gov registry record · NA

Acute Cryotherapy on Musculoskeletal Function and Biomarkers

A NA study, sponsored by University of Texas, El Paso.

Not yet
Registry status
NA
Development phase
60
Enrollment target

NCT07211412 is a NA study that has not yet begun recruiting, run by University of Texas, El Paso. The registered enrollment target is 60 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07211412, a NA study, has not yet begun recruiting, sponsored by University of Texas, El Paso.

NOT YET RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

In 2020, Dubois and Esculier proposed a paradigm shift in the acute management of musculoskeletal injuries, advocating for the transition from the traditional PRICE protocol- Protect, Rest, Ice, Compression, Elevation-to the more holistic PEACE \& LOVE framework. This updated model emphasizes Protection, Elevation, Avoiding anti-inflammatories, Compression, and Education, followed by Load, Optimism, Vascularization, and Exercise. Notably, the PEACE \& LOVE approach omits the use of ice, a decision that has sparked considerable debate. While the rationale centers on avoiding interference with the natural inflammatory and regenerative processes, this omission stands in contrast to a substantial body of animal research suggesting that cryotherapy can mitigate secondary tissue injury by reducing inflammation and metabolic activity. Despite its widespread clinical use, human studies have yet to provide conclusive evidence supporting or refuting the efficacy of cryotherapy in acute injury management, leaving clinicians to navigate between tradition, emerging evidence, and evolving philosophies of care. Even though it is important to consider natural inflammation for a better regenerative process, animal models have shown that the original injury can elicit oxidative stress, which will enhance cellular damage (secondary damage) and inflammation. Clinically, it is unknown if this secondary damage would increase functional impairment. Therefore, this proposal will determine if cryotherapy can decrease secondary damage, after exercise-induced muscle damage, and if this decrease is associated to lower inflammation, oxidative stress and functional impairments.

Interventions

  • OTHER Cryotherapy
  • OTHER Eccentric exercise-induced muscle damage

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-10-15
Est. Completion 2026-05-15
Phase NA

Sponsor

University of Texas, El Paso

17 total trials

What the Registry Record Tells You About NCT07211412

The ClinicalTrials.gov registry entry for NCT07211412 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas, El Paso, which has 17 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Cryotherapy is the first listed.

NCT07211412 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07211412 about?

NCT07211412 is a clinical study titled "Acute Cryotherapy on Musculoskeletal Function and Biomarkers". In 2020, Dubois and Esculier proposed a paradigm shift in the acute management of musculoskeletal injuries, advocating for the transition from the traditional PRICE protocol- Protect, Rest, Ice, Compression, Elevation-to the more holistic PEACE \& LOVE framework. This updated model emphasizes Protec...

What is the current status of trial NCT07211412?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-10-15. Estimated completion is 2026-05-15.

What interventions are being tested in trial NCT07211412?

The interventions under investigation include: Cryotherapy (OTHER), Eccentric exercise-induced muscle damage (OTHER).

Who is sponsoring clinical trial NCT07211412?

This trial is sponsored by University of Texas, El Paso, which has 17 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.